HER2-positive breast cancers are characterized by reprogrammed glycolysis, tricarboxylic acid (TCA) cycle, pentose phosphate pathway (PPP), and glutamine and fatty acid metabolism pathways [21]. This evidence concerns the gene ERBB2 and breast cancer.